Kato Satoshi, Murakami Hideki, Demura Satoru, Yoshioka Katsuhito, Kawahara Norio, Tomita Katsuro, Tsuchiya Hiroyuki
Department of Orthopaedic Surgery, Kanazawa University School of Medicine, Kanazawa, Japan,
Ann Surg Oncol. 2014 Apr;21(4):1330-6. doi: 10.1245/s10434-013-3333-7. Epub 2013 Oct 23.
There are many reports of en bloc resection for spinal tumors. However, no studies have evaluated the clinical outcomes with follow-up exceeding 10 years after surgery.
We reviewed 82 patients who had undergone total en bloc spondylectomy (TES) before January 2002 and identified 29 (19 with primary tumors and 10 with metastatic tumors) who had survived for more than 10 years after surgery. We evaluated the clinical outcomes including patient-based outcomes using questionnaire. The questionnaire included subjective assessment of the results of TES and SF-36.
Overall, 33 % of patients with metastases from kidney cancer and 25 % of those with metastases from thyroid cancer survived for more than 10 years after TES for solitary spinal metastases. Four patients with metastatic tumors had no evidence of disease at the time of survey. There were no tumor recurrences in any of the 23 patients who underwent TES as the primary surgery. No revision surgeries have been required as a result of instrumentation failure in any of the 29 patients. About 90 % of the patients were satisfied or very satisfied with the results of TES. The SF-36 results demonstrated that the both physical and mental health of patients with primary tumors was equivalent to those of healthy individuals, and the mental health of patients with metastatic tumors was almost similar to them.
This study showed the long-term clinical outcomes after TES to be favorable. TES played an important role in the treatment strategy for spinal tumors including metastases.
有许多关于脊柱肿瘤整块切除的报道。然而,尚无研究评估手术后随访超过10年的临床结果。
我们回顾了2002年1月前接受全椎体整块切除术(TES)的82例患者,确定了29例(19例原发性肿瘤和10例转移性肿瘤)术后存活超过10年的患者。我们使用问卷评估临床结果,包括基于患者的结果。问卷包括对TES结果和SF-36的主观评估。
总体而言,对于孤立性脊柱转移瘤,肾癌转移患者中有33%、甲状腺癌转移患者中有25%在TES后存活超过10年。4例转移性肿瘤患者在调查时无疾病证据。23例接受TES作为初次手术的患者均未出现肿瘤复发。29例患者中无一例因器械故障需要翻修手术。约90%的患者对TES结果满意或非常满意。SF-36结果表明,原发性肿瘤患者的身心健康与健康个体相当,转移性肿瘤患者的心理健康与他们几乎相似。
本研究表明TES后的长期临床结果良好。TES在包括转移瘤在内的脊柱肿瘤治疗策略中发挥了重要作用。